Recurrent hydropneumothorax: An unusual presentation for malignant pleural mesothelioma

Respiratory Medicine Case Reports 2016 July 12 [Link] DeLapp D1, Chan C1, Nystrom P Abstract Mesothelioma is a rare pulmonary malignancy commonly associated with asbestos exposure. Its presentation is insidious and non-specific, with complaints of chest pain, dyspnea and cough. Chest X-ray may demonstrate unilateral pleural effusion. CT and PET scans may highlight nodular pleural…

Read More

Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group

Lung Cancer 2015 July 29 [Epub ahead of print] [Link] Armato SG 3rd, Coolen J, Nowak AK, Robinson C, Gill RR, Straus C, Khanwalkar A. Abstract Imaging of malignant pleural mesothelioma is essential to patient management, prognostication, and response assessment. From animal models to clinical trials, the gamut of research activities and clinical standards relies…

Read More

Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?

Respiration 2015 May 8 [Epub ahead of print] [Link] Pinelli V, Roca E, Lucchini S, Laroumagne S, Loundou A, Dutau H, Maldonado F, Astoul P. Abstract Background Careful clinical staging in patients with malignant pleural mesothelioma (MPM) is fundamental in management planning. Positron emission tomography/computed tomography (PET/CT) is increasingly recognized as an important staging modality.…

Read More

Use of Computed Tomography and Positron Emission Tomography/Computed Tomography for Staging of Local Extent in Patients With Malignant Pleural Mesothelioma

Journal of Computer Assisted Tomography 2014 Oct 28 [Epub ahead of print] [Link] Frauenfelder T, Kestenholz P, Hunziker R, Nguyen TD, Fries M, Veir Haibach P, Husmann L, Stahel R, Weder W, Opitz I. Abstract Purpose The objective of this study was to determine the diagnostic value of computed tomography (CT) and positron emission tomography…

Read More

Aggressive poorly differentiated adenocarcinoma of the lung diagnosed 13 months after initial diagnosis of papillary thyroid carcinoma with “non-iodine concentrating” pulmonary metastasis

Hellenic Journal of Nuclear Medicine. 2012 Sep-Dec;15(3):252-3. [Link] Basu S, Rekhi B, Shamim SA, Jambhekar NA. Radiation Medicine Centre (B.A.R.C), Tata Memorial Centre Annexe, Jerbai Wadia Road, Parel, Mumbai 400012, India. drsanb@yahoo.com. Abstract An aggressive second primary in the form of a lung adenocarcinoma with a rapidly progressive fatal course is described in the setting…

Read More

18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: Looking from outside is not enough

Lung Cancer.. 2012 Nov 30. pii: S0169-5002(12)00619-8. doi: 10.1016/j.lungcan.2012.10.017. [Epub ahead of print] [Link] Roca E, Laroumagne S, Vandemoortele T, Berdah S, Dutau H, Maldonado F, Astoul P. Department of Thoracic Oncology, Pleural Diseases, and Interventional Pulmonology, Hôpital Nord, Marseille, France. Abstract Malignant mesothelioma (MM) is an uncommon neoplasm with a poor prognosis usually associated…

Read More

FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival

European Journal of Nuclear Medicine and Molecular Imaging. 2011 Jan 6. [Epub ahead of print] [Link] Gerbaudo VH, Mamede M, Trotman-Dickenson B, Hatabu H, Sugarbaker DJ. Division of Nuclear Medicine and Molecular Imaging, Brigham & Women’s Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA, vgerbaudo@partners.org. Abstract Purpose: This study investigated the diagnostic…

Read More

Monitoring of Chemotherapy Response in Malignant Pleural Mesothelioma Using Fluorodeoxyglucose Positron Emission Tomography

Internal Medicine. 2008;47(23):2053-6. Epub 2008 Dec 1. [Link] Kimura T, Koyama K, Kudoh S, Kawabe J, Yoshimura N, Mitsuoka S, Shiomi S, Hirata K. Department of Respiratory Medicine, Osaka City University, Osaka. kimutats@med.osaka-cu.ac.jp Abstract We report a 56-year-old man who underwent monitoring of the response to chemotherapy of malignant pleural mesothelioma (MPM). 8F-fluoro-2-deoxy-D-glucose positron emission…

Read More